Your Partner in Clinical Development
Partnering with you through every step of the clinical development journey.
We think differently at AyurDatta – prioritizing your goals as we partner to bring life-changing therapies to patients. We’re aligned with biopharma innovators, delivering flexible, patient-centric clinical trial solutions for more than 20 years. Operating as an extension of your team, we solve issues, reduce risk and deliver high-quality data. Our experience executing complex trials and adeptness in key therapy areas brings valuable insights to fuel your future breakthroughs.
Dedicated leadership to advance your oncology studies
Our integrated team of medical, scientific, and clinical development experts engage early and often to help refine your strategy, improve targeting, and accelerate delivery.
Led by Ashok Srivastava, renowned global expert in Oncology & Hematology, who brings nearly 20 years of experience and a strong record of building high-performing, global teams that drive clinical programs for regulatory approval and commercialization of therapies. Ashok’s teams also bring an adeptness in molecule-to-market strategies and operational excellence. He ensures our ability to provide development strategies while delivering exceptional experiences for our clients conducting oncology, hematology and cell and gene therapy studies.
- From early phase development, FIH, dose escalation in phase 1, safety signal detections and trend analysis to regulatory approval, oncology studies require specific clinical expertise, insight, and diligent patient-centric monitoring to ensure success.
- We understand oncology study intricacies: evolving regulatory landscapes, novel study designs, and personalized treatment approaches that can bring life-saving therapies to patients faster and more effectively.
- Our team is made up of oncologists and investigators who understand the culture, patients, physicians and trial sites, with extensive experience overseeing trials globally.
Rare disease studies, for rare patients
Rare disease studies demand a high level of attention. From designing a protocol with the appropriate inclusion/exclusion criteria to finding eligible patients and securing experienced sites, we work to address your trial’s unique challenges.
- As a nimble solution provider, we’re built to support emerging and mid-sized drug developers by extending the expertise of their teams with our medical, scientific, and clinical specialists.
- We share our experience navigating complexity in rare disease trials and collaborate to design custom solutions that guide development and improve the potential for success.
- Our track record includes advancing 210+ rare disease studies with nearly 19,500 patients across 2,935+ sites.
Our global reach and expertise
Many oncology and rare disease studies need a global reach to maximize patient recruitment. We bring a distinct global reach that empowers us to identify sites and reach rare patients—no matter where they are in the world.
- Prospective trial sites may lack specific rare disease experience; our clinical and medical specialists engage and educate site staff to ensure quality execution.
- We provide high-touch site management while minimizing burden using best practices and customized support.
- We support regulatory strategy, orphan drug designation consultation, and guidance for global submissions.
Ready to learn more? Contact us or explore our services.